PYXS — Pyxis Oncology Share News
0.000.00%
Last trade - 00:00- $200.90m
- $167.90m
- $13.86m
Brief: Pyxis Oncology Reports Q2 Financial Results
Brief: Pyxis Oncology Reports Q1 Loss Per Share $0.97
Brief: Pyxis Oncology Announces Leadership Changes
Brief: Biosion Licenses BSI-060T (Anti-Siglec-15) To Pyxis Oncology
Brief: Pyxis Oncology Inc - Cash Runway Sufficient For Multiple Milestones Through Q3 2024
Brief: Pyxis Oncology Inc To Be Added To Russell 2000 Index
Brief: Pyxis Oncology Appoints Martina Molsbergen As Interim Chief Business Officer
Brief: Pyxis Reports Financial Results For The Third Quarter Of 2021 And Provides Business Update
Portfolio Company Update: Pyxis IPO
Pfizer-backed Pyxis Oncology wobbles on debut after IPO upsized
Brief: Pyxis Oncology Shares Open 18.75% Above IPO Price in Nasdaq debut
NASDAQ RESUMED AT 11:01 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:59 AM